The Potential Role of Contraction-Induced Myokines in the Regulation of Metabolic Function for the Prevention and Treatment of Type 2 Diabetes

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2017 May 18

PMID 28512448

Citations 24

Authors

Brian P Carson

Affiliations

Soon will be listed here.

Abstract

Skeletal muscle represents the largest organ in the body, comprises 36-42% of body weight, and has recently been recognized as having an endocrine function. Proteins expressed and released by muscle that have autocrine, paracrine, and endocrine bioactivities have been termed myokines. It is likely that muscle contraction represents the primary stimulus for the synthesis and secretion of myokines to enable communication with other organs such as the liver, adipose tissue, brain, and auto-regulation of muscle metabolism. To date, several hundred myokines in the muscle secretome have been identified, a sub-population of which are specifically induced by skeletal muscle contraction. However, the bioactivity of many of these myokines and the mechanism through which they act has either not yet been characterized or remains poorly understood. Physical activity and exercise are recognized as a central tenet in both the prevention and treatment of type 2 diabetes (T2D). Recent data suggest humoral factors such as muscle-derived secretory proteins may mediate the beneficial effects of exercise in the treatment of metabolic diseases. This mini-review aims to summarize our current knowledge on the role of contraction-induced myokines in mediating the beneficial effects of physical activity and exercise in the prevention and treatment of T2D, specifically glucose and lipid metabolism. Future directions as to how we can optimize contraction-induced myokine secretion to inform exercise protocols for the prevention and treatment of T2D will also be discussed.

Citing Articles

Brain-Periphery Axes: The Potential Role of Extracellular Vesicles-Delivered miRNAs.

DAmico G, Carista A, Manna O, Paladino L, Picone D, Sarullo S Biology (Basel). 2025; 13(12.

PMID: 39765723 PMC: 11673379. DOI: 10.3390/biology13121056.

Equine Asthma Does Not Affect Circulating Myostatin Concentrations in Horses.

Kowalik S, Oreilly M, Niedzwiedz A, Kedzierski W Animals (Basel). 2024; 14(5).

PMID: 38473184 PMC: 10931188. DOI: 10.3390/ani14050799.

Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression.

Veluthakal R, Esparza D, Hoolachan J, Balakrishnan R, Ahn M, Oh E Int J Mol Sci. 2024; 25(3).

PMID: 38338783 PMC: 10855860. DOI: 10.3390/ijms25031504.

Combined effects of exercise and different levels of acute hypoxic severity: A randomized crossover study on glucose regulation in adults with overweight.

Tee C, Parr E, Cooke M, Chong M, Rahmat N, Md Razali M Front Physiol. 2023; 14:1174926.

PMID: 37123278 PMC: 10133678. DOI: 10.3389/fphys.2023.1174926.

Upregulation of CCL5/RANTES Gene Expression in the Diaphragm of Mice with Cholestatic Liver Disease.

Morales V, Gonzalez A, Cabello-Verrugio C Adv Exp Med Biol. 2023; 1408:201-218.

PMID: 37093429 DOI: 10.1007/978-3-031-26163-3_11.

References

Gorgens S, Hjorth M, Eckardt K, Wichert S, Norheim F, Holen T . The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation. Acta Physiol (Oxf). 2015; 216(3):330-45. DOI: 10.1111/apha.12579. View

Wolsk E, Mygind H, Grondahl T, Pedersen B, van Hall G . IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010; 299(5):E832-40. DOI: 10.1152/ajpendo.00328.2010. View

Gorgens S, Raschke S, Bjorklund Holven K, Jensen J, Eckardt K, Eckel J . Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells. Arch Physiol Biochem. 2013; 119(2):75-80. DOI: 10.3109/13813455.2013.768270. View

Mashili F, Austin R, Deshmukh A, Fritz T, Caidahl K, Bergdahl K . Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev. 2011; 27(3):286-97. DOI: 10.1002/dmrr.1177. View

Fiuza-Luces C, Garatachea N, Berger N, Lucia A . Exercise is the real polypill. Physiology (Bethesda). 2013; 28(5):330-58. DOI: 10.1152/physiol.00019.2013. View

Eckardt K, Gorgens S, Raschke S, Eckel J . Myokines in insulin resistance and type 2 diabetes. Diabetologia. 2014; 57(6):1087-99. DOI: 10.1007/s00125-014-3224-x. View

Yarrow J, White L, McCoy S, Borst S . Training augments resistance exercise induced elevation of circulating brain derived neurotrophic factor (BDNF). Neurosci Lett. 2010; 479(2):161-5. DOI: 10.1016/j.neulet.2010.05.058. View

Perakakis N, Triantafyllou G, Fernandez-Real J, Huh J, Park K, Seufert J . Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13(6):324-337. PMC: 5878942. DOI: 10.1038/nrendo.2016.221. View

Xu J, Stanislaus S, Chinookoswong N, Lau Y, Hager T, Patel J . Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab. 2009; 297(5):E1105-14. DOI: 10.1152/ajpendo.00348.2009. View

10.

Loffler D, Muller U, Scheuermann K, Friebe D, Gesing J, Bielitz J . Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab. 2015; 100(4):1289-99. DOI: 10.1210/jc.2014-2932. View

11.

Carbo N, Lopez-Soriano J, Costelli P, Alvarez B, Busquets S, Baccino F . Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta. 2001; 1526(1):17-24. DOI: 10.1016/s0304-4165(00)00188-4. View

12.

Bernardo B, Lu M, Bandyopadhyay G, Li P, Zhou Y, Huang J . FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance. Sci Rep. 2015; 5:11382. PMC: 4495598. DOI: 10.1038/srep11382. View

13.

Quinn L, Anderson B, Strait-Bodey L, Stroud A, Argiles J . Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2008; 296(1):E191-202. PMC: 2636988. DOI: 10.1152/ajpendo.90506.2008. View

14.

Carey A, Steinberg G, Macaulay S, Thomas W, Holmes A, Ramm G . Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55(10):2688-97. DOI: 10.2337/db05-1404. View

15.

Huh J, Siopi A, Mougios V, Park K, Mantzoros C . Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab. 2014; 100(3):E453-7. DOI: 10.1210/jc.2014-2416. View

16.

Steensberg A, Febbraio M, Osada T, Schjerling P, van Hall G, Saltin B . Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol. 2001; 537(Pt 2):633-9. PMC: 2278951. DOI: 10.1111/j.1469-7793.2001.00633.x. View

17.

Pedersen B, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P . Searching for the exercise factor: is IL-6 a candidate?. J Muscle Res Cell Motil. 2003; 24(2-3):113-9. DOI: 10.1023/a:1026070911202. View

18.

Krolopp J, Thornton S, Abbott M . IL-15 Activates the Jak3/STAT3 Signaling Pathway to Mediate Glucose Uptake in Skeletal Muscle Cells. Front Physiol. 2017; 7:626. PMC: 5167732. DOI: 10.3389/fphys.2016.00626. View

19.

Tamura Y, Watanabe K, Kantani T, Hayashi J, Ishida N, Kaneki M . Upregulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?. Endocr J. 2011; 58(3):211-5. DOI: 10.1507/endocrj.k10e-400. View

20.

Tsuchida A, Nonomura T, Nakagawa T, Itakura Y, Ono-Kishino M, Yamanaka M . Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Diabetes Obes Metab. 2002; 4(4):262-9. DOI: 10.1046/j.1463-1326.2002.00206.x. View